Education
About Us
Working with TipRanks
Follow Us
Corteva (CTVA)
NYSE:CTVA
CTVA Stock Chart & Stats
$80.12
-$0.33(-0.58%)
At close: 4:00 PM EST
$80.12
-$0.33(-0.58%)
Day’s Range― - ―
52-Week Range$53.40 - $80.23
Previous CloseN/A
Volume628.04K
Average Volume (3M)3.98M
Market Cap
$53.88B
Enterprise Value$51.94B
Total Cash (Recent Filing)$4.53B
Total Debt (Recent Filing)$2.58B
Price to Earnings (P/E)49.9
Beta0.58
Next Earnings
May 06, 2026EPS Estimate
1.17Next Dividend Ex-DateN/A
Dividend Yield1.04%
Share Statistics
EPS (TTM)0.22
Shares Outstanding672,524,000
10 Day Avg. Volume3,690,645
30 Day Avg. Volume3,980,646
Financial Highlights & Ratios
PEG Ratio1.80
Price to Book (P/B)1.87
Price to Sales (P/S)2.59
P/FCF Ratio16.03
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue2.98
Enterprise Value/Gross Profit6.44
Enterprise Value/Ebitda16.91
Forecast
1Y Price Target
$84.55Price Target Upside5.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)3.63
Revenue Forecast (FY)$18.09B
Bulls Say, Bears Say
Bulls Say
Earnings Guidance UpsideAnalyst points out that conservative company guidance leaves room for upward analyst estimate revisions if agricultural conditions and currency trends remain supportive, potentially driving share gains.
Financial Flexibility And Strategic DealsAnalyst notes strong free cash flow and improved working capital that enhance financial flexibility to pursue partnerships or investments, supporting future growth opportunities.
Seed Business ValuationAnalyst highlights that the Seed business's strong operating performance supports assigning a higher valuation multiple once separated, which could elevate the overall stock valuation.
Bears Say
Crop Chemicals CompetitivenessAnalyst cautions the Crop Chemical business may face sales challenges and derating as a standalone operation amid rising generic competition and unresolved litigation risks, which could weaken revenue prospects.
Profitability And Valuation HeadwindsAnalyst views the stock's move toward prior targets, along with higher interest costs and adverse currency effects, as factors that balance upside potential and support a Neutral stance on valuation.
Separation Execution RiskAnalyst warns that the planned separation of Seed and Crop Chemical businesses increases execution risk, with potential loss of synergies and higher costs that could pressure margins.
Corteva News
CTVA FAQ
What was Corteva’s price range in the past 12 months?
Corteva lowest stock price was $53.40 and its highest was $80.22 in the past 12 months.
What is Corteva’s market cap?
Corteva’s market cap is $53.88B.
When is Corteva’s upcoming earnings report date?
Corteva’s upcoming earnings report date is May 06, 2026 which is in 65 days.
How were Corteva’s earnings last quarter?
Corteva released its earnings results on Feb 03, 2026. The company reported $0.22 earnings per share for the quarter, missing the consensus estimate of $0.223 by -$0.003.
Is Corteva overvalued?
According to Wall Street analysts Corteva’s price is currently Undervalued.
Does Corteva pay dividends?
Corteva pays a Quarterly dividend of $0.18 which represents an annual dividend yield of 1.04%. See more information on Corteva dividends here
What is Corteva’s EPS estimate?
Corteva’s EPS estimate is 1.17.
How many shares outstanding does Corteva have?
Corteva has 672,524,000 shares outstanding.
What happened to Corteva’s price movement after its last earnings report?
Corteva reported an EPS of $0.22 in its last earnings report, missing expectations of $0.223. Following the earnings report the stock price went up 0.107%.
Which hedge fund is a major shareholder of Corteva?
Currently, no hedge funds are holding shares in CTVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Corteva Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$84.55 (5.52% Upside)
$84.55 (5.52% Upside)
Blogger Sentiment
Bullish
CTVA Sentiment 100%
Sector Average 65%
Sector Average 65%
Hedge Fund Trend
Decreased
By 786.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $636.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.3%
Last 30 Days ▲ 5.8%
Last 30 Days ▲ 5.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.84%
12-Months-Change
Fundamentals
Return on Equity
4.98%
Trailing 12-Months
Asset Growth
4.95%
Trailing 12-Months
Company Description
Corteva
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.
CTVA Company Deck
CTVA Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a broadly positive outlook driven by strong 2025 results (14% EBITDA growth, margin expansion to >22%, $2.9B FCF), successful strategic progress (Bayer settlement accelerating licensing and reducing royalty risk), and reiterated 2026 guidance with continued productivity targets. Key near-term risks include Q4 timing-related volume softness, competitive pricing pressures in Crop Protection (notably Brazil), currency headwinds in 2025 and expected tariff impacts in 2026, along with higher SG&A/R&D and potential normalization of working capital that could temper free cash flow. On balance, the company highlighted more material progress and upside catalysts than offsets, with a clear path to additional licensing revenue and margin/cash improvement.View all CTVA earnings summariesCTVA Revenue Breakdown
40.24% Corn
10.79% Soybean
3.70% Other oilseeds
2.15% Other
21.44% Herbicides
9.59% Insecticides
6.55% Fungicides
2.98% Biologicals
2.56% Other
CTVA Stock 12 Month Forecast
Average Price Target
$84.55
▲(5.52% Upside)
Technical Analysis
Ownership Overview
0.15% Insiders
28.16% Mutual Funds
13.29% Other Institutional Investors
33.09% Public Companies and Individual Investors